Skip to content

Net margin at other companies

Royalty Pharma logo
Royalty PharmaRPRX
33.9%-14.4pp
LQD
Liquidia CorporationLQDA
-176.2%-76.4pp
Revvity logo
RevvityRVTY
8.3%-2.1pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-125.9%-54.5pp
Roivant Sciences logo
Roivant SciencesROIV
-6,079.9%-6,193pp
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-140.2%-169pp

Other financials

Income statement

See full
Revenue$51.7M+14.1%
Operating income$17.4M+148%
Net income-$13.3M+68.6%
EPS (diluted)-$0.67+69.7%

Balance sheet

See full
Cash & equivalents$115.1M+140%
Total debt$5.1M+14.2%
Total equity$997.3M+25.4%
Total assets$1.5B+69.2%

Cash flow

See full
Operating cash flow$48.7M+291%
CapEx$228.0K+6.5%
Free cash flow$48.5M+289%

Valuation

See full
Market cap$5.51B+96.7%
Enterprise value$5.4B+95.4%
P/E35.9×
P/S20.1×+4.6×

Profitability

See full
Gross margin91.9%
Operating margin34.5%+23.0pp
FCF margin44.8%+16.8pp

Returns & leverage

See full
Return on equity17.1%+11.5pp
Debt / equity0.0×
Current ratio21.3×+16.0×

Where this comes from

Calculated from Ligand Pharmaceuticals’s reported figures.

Based on trailing twelve months.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ligand Pharmaceuticals's net margin?
Ligand Pharmaceuticals (LGND) reported net margin of 55.9% in Q1 2026.
How has Ligand Pharmaceuticals's net margin changed year-over-year?
Ligand Pharmaceuticals's net margin increased by 176.6% year-over-year, from -73.1% to 55.9%.
What is the long-term trend for Ligand Pharmaceuticals's net margin?
Over 5 years (2020 to 2025), Ligand Pharmaceuticals's net margin has grown at a 96.1% compound annual growth rate (CAGR), from -1.6% to 46.4%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.